Association of Sclerostin with Bone Metabolism and Bone Mineral Density in Adults with Type 1 Diabetes Mellitus
Neslihan Soysal-Atile, Bülent Bilir, Betül Uğur-Altun, Betül Ekiz-Bilir & Hüseyin Çelik · Journal of Advances in Medicine and Medical Research · 2016
Aims: Type 1 DM (T1DM) patients are shown having lower bone mineral density (BMD). Wnt signaling pathway is important in bone homestasis. Sclerostin is a major inhibitor of this pathway. The objectives of our study are to evaluate sclerostin levels of T1DM patients and to analyse...
Open access
Research Article
10.9734/BJMMR/2016/25400